Tivic Named to Fast Company’s Annual List of the World’s Most Innovative Companies 2023 In the Medical Device Category
March 02 2023 - 12:00PM
Business Wire
Bioelectronic Medicine Recognized
Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a
commercial-phase health technology company that develops and
commercializes bioelectronic medicine, has been named to Fast
Company’s prestigious annual list of the World’s Most Innovative
Companies for 2023 in the Medical Device category. Tivic’s first
commercial product, ClearUP, is an FDA approved and CE-Marked
bioelectronic sinus device and the first of its kind to reduce
symptoms of inflammation such as sinus pain, sinus headaches, and
congestion.
Tivic is driving the adoption of bioelectronic medicine -- a
rapidly emerging field that uses electronic devices to treat and
manage disease. The benefits of this approach are numerous -- the
ability to precisely target and modulate specific biological
pathways, the potential for fewer side effects compared to
traditional drugs, and the ability to treat a variety of
conditions.
This year’s list highlights the businesses at the forefront of
their respective industries, paving the way for the innovations of
tomorrow. These companies are setting the standard with some of the
greatest accomplishments of the modern world. In addition to the
World’s 50 Most Innovative Companies, 540 organizations are
recognized across 54 sectors and regions.
“We are honored to be selected by the editors of Fast Company
for the work we are doing to advance the field of bioelectronic
medicine,” said Jennifer Ernst, CEO of Tivic. “This award validates
not only our current offering, but also the opportunities to expand
our therapeutic portfolio.”
“What a strange and thrilling year it has been to honor this
year’s Most Innovative Companies. This year’s list compiles some of
the most cutting-edge groundbreakers who are changing our world
every single day, from legacy organizations like McDonald’s to
upstarts like MrBeast and institutions such as NASA. Everyone on
this list does something completely, uniquely different, yet, they
all have one thing in common: innovation,” said Fast Company
editor-in-chief Brendan Vaughan.
In 2021, Tivic’s ClearUP was named to Fast Company’s Next Big
Things in Tech, and in 2020 ClearUP received honorable mention,
consumer products in Fast Company’s World Changing Ideas Award.
Fast Company will host its third annual Most Innovative
Companies Summit on April 19 and 20. The virtual summit celebrates
the Most Innovative Companies in business, and provides an inside
look at cutting-edge business trends and what it takes to innovate
in 2023. Fast Company’s Most Innovative Companies issue
(March/April 2023) is available online here, as well as in-app form
via iTunes, and on newsstands beginning March 14. The hashtag is
#FCMostInnovative.
About Fast Company
Fast Company is the only media brand fully dedicated to the
vital intersection of business, innovation, and design, engaging
the most influential leaders, companies, and thinkers on the future
of business. Headquartered in New York City, Fast Company is
published by Mansueto Ventures LLC, along with our sister
publication Inc., and can be found online at
www.fastcompany.com.
About Tivic
Tivic Health Systems, Inc. is a commercial-phase health
technology company delivering non-invasive bioelectronic treatments
that provide consumers with a choice in the treatment of
inflammation and certain other related conditions. For more
information visit https://tivichealth.com @TivicHealth.
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors. Given the
existence of such risks and uncertainties, you are cautioned not to
place undue reliance on such forward-looking statements. For a
discussion of certain risks and uncertainties, and other important
factors relevant to the company, any of which could cause Tivic’s
actual results to differ from those contained in the
forward-looking statements, see Tivic’s filings with the SEC,
including, its Annual Report on Form 10-K for the year ended
December 31, 2021, filed with the SEC on March 31, 2022, under the
heading “Risk Factors”; its Registration Statement on S-1, filed
with the SEC on October 26, 2022, and amendments thereto, under the
heading “Risk Factors”; as well as the company’s subsequent filings
with the SEC. Forward-looking statements contained in this press
release are made as of this date, and Tivic Health Systems, Inc.
undertakes no duty to update such information except as required by
applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230302005674/en/
Media Contact: Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com 617-429-6749 Investor
Contact: Hanover International, Inc. ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Apr 2024 to May 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From May 2023 to May 2024